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Activation of pattern recognition receptors on den-
dritic cells (DCs) and macrophages leads to secre-
tion of cytokines that control differentiation of CD4+
T cells. The current understanding is that inter-
leukin-6 (IL-6) in combination with transforming
growth factor-b (TGF-b) leads to generation of T
helper 17 (Th17) lineage cells. Here, we have discov-
ered that the cytokine requirements for Th17 cell
polarization depend on the site of priming. Although
IL-6 played a critical role in Th17 cell lineage priming
in the skin and mucosal tissues, it was not required
for Th17 cell priming in the spleen. In contrast, IL-1
played an irreplaceable role for priming of Th17
lineage cells in all tissues. Importantly, we have
demonstrated that IL-6-independent and -depen-
dent pathways of Th17 cell differentiation are guided
by DCs residing in various tissues. These results
reveal fundamental differences by which the sys-
temic, mucosal, and cutaneous immune systems
guide Th17 cell lineage commitment.
INTRODUCTION
Activation of the innate immune system is critical for inducing
priming of antigen-specific naive CD4+ T cells (Janeway, 1989;
Medzhitov, 2001). Dendritic cells (DCs) are equipped with a
broad array of pattern recognition receptors (PRRs), such as
Toll-like receptors (TLRs) (Iwasaki andMedzhitov, 2004), retinoic
acid-inducible gene I (RIG-I)-like receptors (Meylan et al., 2006),
nucleotide-binding oligomerization domain-containing protein
(NOD)-like receptors (NLRs) (Williams et al., 2010), and C-type
lectin receptors (Geijtenbeek and Gringhuis, 2009), all of which
sense pathogen-associated molecular patterns (PAMPs) and
trigger DC maturation. Maturation of DCs is characterized by
high expression of major histocompatibility complex (MHC)
and costimulatory molecules, as well as the production of in-
flammatory cytokines and chemokines, which play critical roles
in activation of naive T cells (Palm and Medzhitov, 2009).
In addition to naive T cell priming, cytokines secreted by DCs
after PRR engagement govern the fate of activated CD4+ T cells
and regulate their survival and lineage commitment (Zhu et al.,1010 Immunity 35, 1010–1022, December 23, 2011 ª2011 Elsevier In2010). Cytokines such as IL-12 and IL-18 initiate or promote
T helper 1 (Th1) cell commitment of primed T cells, which protect
the host against various bacterial and viral pathogens (Hsieh
et al., 1993; Takeda et al., 1998). A newly defined lineage of
T cells, called T helper 17 (Th17) cells, has been shown to be crit-
ical for protection against certain bacterial and fungal infections
and also to be responsible for several autoimmune diseases
(Korn et al., 2009). The orphan nuclear receptor RORgt has
been shown to be both necessary and sufficient for Th17 cell
differentiation (Ivanov et al., 2006; Yang et al., 2008b). A combi-
nation of interleukin-6 (IL-6) and transforming growth factor-
b (TGF-b), in vitro, leads to induction of the transcription factor
RORgt and differentiation of murine naive T cells into Th17
lineage cells (Bettelli et al., 2006; Manel et al., 2008; Mangan
et al., 2006; Veldhoen et al., 2006). Other studies have demon-
strated that IL-1 enhances Th17 cell differentiation induced by
a combination of IL-6, TGF-b, IL-23, or IL-21 (Acosta-Rodriguez
et al., 2007; Korn et al., 2007; Nurieva et al., 2007; Volpe et al.,
2008; Yang et al., 2008a; Zhou et al., 2007). Furthermore, inter-
leukin-1 receptor-deficient (Il1r1/) mice have been shown to
be resistant to experimental autoimmune encephalomyelitis
(EAE) (Sutton et al., 2006) and, most recently, IL-6 has been
shown to control Th17 cell differentiation through regulation of
IL-1R on CD4+ T cells (Chung et al., 2009). However, the relative
contributions of IL-1 and IL-6 in Th17 cell differentiation are not
completely understood.
Multicellular organisms constantly encounter microbial stim-
uli, from both commensals and invading pathogens. Most
microbes invade their hosts through the mucosal surfaces
such as the intestine, the respiratory tract, and the uro-genital
tract, as well as the skin. Adaptive immune responses to patho-
gens are generated in the draining lymph nodes of the site of
infection. However, pathogens also penetrate into the blood-
stream and cause systemic infection, and adaptive immune
responses to such pathogens are generated in the spleen. The
mucosal immune system, the cutaneous immune system, and
the systemic immune system face unique challenges in dealing
with infectious agents. The former two are in constant contact
with commensal micro-organsims whereas the spleen is largely
a sterile environment. In addition, unique DC populations reside
in different tissues. Broadly, DCs can be categorized into tissue-
resident and lymphoid organ-resident DCs (Villadangos and
Schnorrer, 2007). The former reside in peripheral tissues such
as mucosa, skin, and nonlymphoid organs and migrate from
peripheral tissues into the corresponding lymph nodes, through
the afferent lymphatics (Randolph et al., 2005), both at steadyc.
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DCs enter the spleen and lymph nodes as bone-marrow-derived
precursors and develop within those organs without trafficking
through peripheral tissues (Liu et al., 2007). The spleen contains
exclusively blood-derived DCs, whereas the lymph nodes in
addition to blood-derived DC subsets contain migratory DCs
coming from peripheral tissues (Henri et al., 2001). Although
we understand that DCs play a critical role in activation of naive
T cells, the importance of anatomical location of DCs for T cell
differentiation remains largely unexplored.
In the current study we discovered that Th17 cell lineage
commitment has differential cytokine requirements depending
on the site of priming. We have shown that IL-6, which is thought
to be a necessary differentiation factor for Th17 cell lineage
development, was critical in the mucosal tissues of the gut and
lungs as well as in the skin draining lymph nodes but not in the
spleen. However, IL-1R signaling was critical for induction of
IL-17-secreting T cells in all tissues. We have further demon-
strated that DC populations resident in the mucosal tissues,
skin, and spleen were responsible for the differential cytokine
requirements for Th17 cell priming. This study provides impor-
tant insights into how priming microenvironments guide the
cytokine requirements for development of Th17 lineage cells
and demonstrates that DC populations from sterile microenvi-
ronments and commensal inhabited microenvironments impose
different rules for Th17 cell priming.
RESULTS
MyD88 Adaptor Signaling in T Cells Is Critical for
Inducing Antigen-Specific Th17 Cells
Depletion of CD4+CD25+ regulatory T (Treg) cells in Myd88/
mice restores otherwise defective antigen-specific CD4+ T cell
priming as well as Th1 cell commitment (Pasare and Medzhitov,
2004). We investigated whether such priming would also restore
Th17 cell lineage commitment in Myd88/ mice. As demon-
strated before, immunization of Myd88/ mice via antigen
mixed with TLR4 ligand lipopolysaccharide (LPS), after in vivo
depletion of Treg cells (Figures S1A and S1B available online),
led to priming of interferon-g (IFN-g)-producing T cells (Fig-
ure 1A). Intriguingly, CD4+ T cells from Treg cell-depleted
Myd88/ mice failed to secrete detectable IL-17A (IL-17) (Fig-
ure 1A). To explore the possibility that a lack of IL-6 and IL-23
secretion by DCs could be the cause of defective Th17 cell
priming in Myd88/ mice, we used a transgenic mouse ex-
pressingMyD88 only in DCs andmacrophages under the control
of the Cd11c promoter (Pasare and Medzhitov, 2005) (Cd11c-
Myd88 Tg). DCs from the Cd11c-Myd88 Tg mice had normal
TLR-induced IL-6 and IL-23 secretion (Figure S1C). Strikingly,
these mice had normal Th1 cell priming but defective Th17 cell
priming (Figure 1B), demonstrating that restoring TLR signaling
in DCs was insufficient to induce antigen-specific Th17 cell
priming.
In our in vitro priming assays, WT T cells differentiated into
both Th1 and Th17 cell lineages (Figure 1C). However,Myd88/
T cells differentiated into IFN-g-producing Th1 cells but not
IL-17-producing Th17 cells (Figure 1C). Because MyD88 is an
adaptor molecule shared by TLRs and the IL-1 receptor (Wesche
et al., 1997), we tested the ability of Il1r1/ T cells to differentiateImminto Th17 cells and found that Il1r1/ CD4+ T cells behaved like
Myd88/ CD4+ T cells in terms of IL-17 production (Figure 1D).
This is consistent with a previously suggested role for IL-1R sig-
naling in CD4+ T cells for Th17 cell differentiation (Chung et al.,
2009; Sutton et al., 2006). A very surprising result, however,
was that Il6/ DCs were able to induce Th17 cell differentiation
comparable to their WT counterparts (Figure 1E). These data
suggest that IL-1 is critical and IL-6 is dispensable for Th17
cell lineage commitment. Because the current understanding is
that IL-6 is critical for Th17 cell priming (Korn et al., 2009), these
results led us to revisit the paradigm and further investigate
in vivo requirements for Th17 cell lineage commitment.
Th17 Cells Are Present in the Peripheral Secondary
Lymphoid Organs but Not in the Intestinal Lamina
Propria of Il6–/– Mice
Because our in vitro data suggested that IL-6 is dispensable for
Th17 cell lineage commitment, we investigated the status of
Th17 cells in Il6/ mice. In the spleens of Il6/ mice, we found
that CD62LloCD44hi memory CD4+ T cells secreted IFN-g when
activated ex vivo, similar to their WT counterparts (Figure 2A).
Surprisingly, memory cells derived from the spleens of Il6/
mice also secreted IL-17 comparable to the quantities secreted
by WT CD4+ T cells. The percentage of memory CD4+ T cells
making IL-17 was also comparable between WT and Il6/
mice (Figures 2B and 2C). In agreement with our in vitro data,
memory CD4+ T cells from both Myd88/ and Il1r1/ mice
were defective in the secretion of IL-17 (Figure S2A). We next
measured the expression of the Th17 cell lineage master
regulator RORgt and found that memory T cells obtained from
both WT and Il6/ mice expressed similar quantities of this
transcription factor, both at the mRNA (Figure 2D) and the
protein (Figure 2E) level. The RORgt-expressing memory CD4+
T cells from Il6/ mice also express CCR6, a chemokine re-
ceptor known to be preferentially expressed by Th17 cells (Fig-
ure 2F; Hirota et al., 2007). Overall, Il6/ mice seem to have
Th17 cells that are phenotypically indistinguishable from those
in the spleen of WT mice.
These data differ from earlier findings demonstrating that IL-6
plays a nonredundant role in Th17 cell lineage commitment
(Bettelli et al., 2006; Ivanov et al., 2006). However, many earlier
reports have used recombinant cytokine cocktails for in vitro
differentiation assays. Likewise, in vivo studies have dealt mainly
with analyzing cytokine commitment in the CD4+ T cells derived
from the lamina propria (LP) of the intestines. We therefore
decided to investigate Th17 cell commitment of CD4+ T cells
derived from the LP. Of note, because certain components of
the intestinal microflora have been shown to favor the induction
of Th17 cells (Ivanov et al., 2009), mice were cohoused for at
least 2 weeks to ensure homogenous microflora populations
between different genotypes. In contrast to our findings in
the spleen, we found that Th17 cell lineage commitment was
defective in LP CD4+ T cells in Il6/ mice (Figures 2G and 2H).
In Myd88/ and Il1r1/ mice, CD4+ T cells from the LP
behaved like CD4+ T cells in the spleen and were defective in
secretion of IL-17 (Figure S2A).
It has been previously reported that TGF-b drives expression
of the transcription factor Foxp3 and leads to generation of
peripherally induced Treg cells (Bettelli et al., 2006; Chen et al.,unity 35, 1010–1022, December 23, 2011 ª2011 Elsevier Inc. 1011
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Figure 1. MyD88-Dependent IL-1R Signaling in T Cells Is Required for Th17 Cell Priming and IL-6 Is Dispensable for Th17 Cell Priming In Vitro
(A) WT andMyd88/mice received rat anti-mouse CD25 antibody (PC61) or control antibody (rat Ig) by intravenous route (25 mg/mouse). Three days later, Treg cell
depletionwasconfirmed(FigureS1A)andmicewere immunized in the footpads (fp)withovalbumin (OVA) (50mg/fp) andLPS (5mg/fp) emulsified in incompleteFreund’s
adjuvant (IFA). CD4+ T cellswerepurified from the draining lymph nodes at day 7 postimmunization and culturedwithTlr2/Tlr4/Bcells as antigen-presenting cells
(APCs) in the presence of titrating doses of OVA for 72 hr. IFN-g (left) and IL-17 (right) concentrations in the culture supernatants were determined by ELISA.
(B)WT andCd11c-Myd88 Tgmicewere immunized in the fpwith OVA (50 mg/fp) and LPS (5 mg/fp) (left) or OVA (50 mg/fp) andCpG (5 mg/fp) (right) emulsified in IFA.
CD4+ T cells were activated to measure IFN-g (top) and IL-17 (bottom) as described above.
(C–E) Purified naiveCD4+ T cells (33 105) from the indicated strainswere cultured in thepresence of purifiedWTsplenicDCsor Il6/ splenic DCs (63 104) andanti-
CD3 (10ng/ml) for5days in thepresenceorabsenceof theTLR ligands.Culturesupernatantswerecollectedandassayed for IFN-g (top) and IL-17 (bottom)byELISA.
Data are representative of three to four independent experiments. Bar graphs represent mean ± SEM.
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Tissue-Specific Requirements for Th17 Cell Priming2003; Marie et al., 2005). However, IL-6 antagonizes Foxp3-
mediated inhibition of RORgt, thus preventing the generation
of Treg cells and promoting the induction of Th17 lineage cells
(Zhou et al., 2008). Because we found that Il6/ mice had
normal Th17 lineage cells that express RORgt in the spleen,
but both were defective in the LP of the gut, we wanted to deter-
mine whether the proportion of Foxp3+ Treg cells was influenced
in these tissues in Il6/ mice. We saw a similar proportion of
CD4+ T cells from the spleens of WT and Il6/mice expressing
Foxp3 (Figures S2B and S2C). However, when we examined LP
lymphocytes, we found that Il6/ mice had approximately
double the proportion of Foxp3+ CD4+ T cells when compared
to WT mice (Figures S2B and S2C). These data suggest that
IL-6 affects the lineage choice between Foxp3+ Treg cells and
Th17 lineage cells only in the LP of the intestines, not in the
spleen.
Differential Requirement of IL-6 for Th17 Cell
Differentiation in Secondary Lymphoid Organs and
Intestinal Lamina Propria
The above observations raised the interesting possibility that
IL-6 could be required for Th17 cell lineage commitment in
a tissue-specific manner. To test this hypothesis, we generated
mice that express a dominant-negative form of gp130, the
signaling subunit of the IL-6 receptor complex (Hibi et al.,
1990; Taga et al., 1989), in T cells under the control of a Cd2
promoter (Cd2-DNIl6st Tg) (Zhumabekov et al., 1995). CD4+
T cells from these mice had diminished phosphorylation of
Stat3 in response to IL-6 (Figure S3A) and failed to show an
enhanced response to a combination of IL-1b and IL-6 in a prolif-
eration assay with anti-CD3 stimulation (Figure S3B). Analysis of
CD4+ T cells from the spleen and LP of Cd2-DNIl6st Tg mice re-
vealed a phenotype similar to Il6/mice, where IL-17-secreting
CD4+ T cells were present in the spleen and lymph nodes but
were reduced in the LP (Figures 3A and 3B).
In order to look at the differentiation of Th1 and Th17 cells in
various tissues, we transferred naive cells pooled from the
spleen and lymph nodes of Cd2-DNIl6st Tg mice into Rag1/
recipients. Commensal microflora cross the intestinal barrier in
Rag1/ mice and this approach would allow us to assess Th1
and Th17 cell differentiation in various organs. We analyzed
T cells from the spleen, liver, LP, and lung of the recipients
7 days posttransfer for the presence of IFN-g- and IL-17-
producing CD4+ T cells. Intracellular staining suggested that
both WT and Cd2-DNIl6st Tg CD4+ T cells committed to Th17
lineage cells in the spleen and the liver (Figure 3C). In contrast,
Cd2-DNIl6st Tg CD4+ T cells were defective in Th17 cell commit-
ment in the LP and the lungs (Figure 3C). Cd2-DNIl6st Tg CD4+
T cells from the spleens of Rag1/ recipients secreted appre-
ciable quantities of IL-17, whereas Cd2-DNIl6st Tg CD4+
T cells from the LP ofRag1/ recipients failed to secrete detect-
able amounts of IL-17 (Figures 3D and 3E). In contrast, Il1r1/
CD4+ T cells recovered from the Rag1/ hosts had defective
IL-17 production in all the organs that were examined
(Figure S3C).
Lack of Th17 cells selectively in the gut in Il6/ and Cd2-
DNIl6st Tg mice may suggest a requirement of IL-6 for the
survival of Th17 cells in the intestine. We tested this possibility
by staining intestinal RORgt+ CD4+ T cells with Annexin V, whichImmmarks early apoptotic cells. There was indeed a small proportion
of RORgt+ Th17 cells in the gut of Il6/ andCd2-DNIl6st Tgmice
(Figure 2G), and the proportions of these cells that stained
positive with Annexin V was comparable to those of WT mice
(Figure S3D). These results argue that IL-6 signaling is not specif-
ically required for the survival of Th17 cells in the gut and favors
the hypothesis that IL-6 is a tissue-specific priming factor for
Th17 cells.IL-6-Independent Priming of Th17 Cells in the Spleen
after Systemic Infection
Because our data suggest a selective requirement of IL-6 for
Th17 cell commitment in mucosal tissues (the intestines and
lungs), but not in spleen both at steady state and during differen-
tiation under lymphopenic conditions (Rag1/ transfer model),
we investigated the generation of Th17 lineage cells during infec-
tion. Oral infection by Citrobactor rodentium led to priming of
Citrobacter-specific Th17 cells in the LP of WT mice, but Th17
cell priming was defective in both Il6/ mice and Il1r1/ mice
(Figures 4A). We were also not able to detect any Citrobacter-
specific Th17 cell response in the mesenteric lymph nodes
of Il6/ mice (Figure S4), indicating that the lack of antigen-
specific Th17 cells in the LP is due to a priming defect rather
than defective migration of activated cells from the site of
priming to the peripheral tissue. Importantly, when mice were in-
fected with S. typhimurium by the intraperitoneal route causing
a systemic infection, comparable Salmonella-specific Th17 cell
priming was observed in WT and Il6/ mice (Figure 4B) in the
spleen. However, there was defective priming of Salmonella-
specific Th17 cells in Il1r1/ mice (Figure 4B). These data
demonstrate that IL-1 is required for generating IL-17-secreting
CD4+ T cells, irrespective of the route of infection, whereas IL-6
is important for inducing Th17 cells in the LP of the intestines
during oral infection but is not required for Th17 cell priming in
the spleen during a systemic infection.Subcutaneous Immunization Fails to Generate Th17
Cells in the Absence of IL-6
Because of the similarities between the mucosal and cuta-
neous immune systems, we sought to determine whether our
findings in the intestine are applicable to the cutaneous
immune system. Although IL-17-secreting CD4+ T cells are
present in the skin-draining lymph nodes in both WT and
Il6/ mice (Figures 5A, S5A, and S5B), it is possible that these
cells are primed in the spleen and subsequently traffic to the
peripheral lymph nodes. Therefore, we tested whether IL-6 is
required to generate fresh antigen-specific Th17 cell responses
during immune responses initiated from the skin. We trans-
ferred OT-II T cells into WT and Il6/ mice and recipients
were immunized in the footpads with ovalbumin and LPS
emulsified in incomplete Freund’s adjuvant (IFA). OT-II T cells
from the immunized WT recipients secreted both IFN-g and
IL-17 (Figure 5B). However, OT-II T cells recovered from
Il6/ recipients secreted only IFN-g but no IL-17, suggesting
that IL-6 is required for Th17 cell priming during subcutaneous
immunization (Figure 5B). Consistently, Cd2-DNIl6st Tg mice
immunized in the footpads generated a much reduced
antigen-specific Th17 cell response (Figure S5C), furtherunity 35, 1010–1022, December 23, 2011 ª2011 Elsevier Inc. 1013
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cells in the skin draining lymph nodes.
Importantly, CD4+ T cells from the gut did not appear to have
an intrinsic defect in becoming Th17 cells, as shown by the fact
that naive CD4+ T cells from the mesenteric lymph nodes (where
gut-homing T cells are primed) could be polarized toward the
Th17 cell lineage, with IL-6 and TGF-b as well as IL-1, IL-23,
and TGF-b, as efficiently as splenic CD4+ T cells (Figures S5D–
S5F). In addition, lack of IL-6 during development did not affect
the ability of CD4+ T cells to become Th17 cells, as shown by
the fact that Th17 cell-polarizing conditions induced similar
amounts of IL-17-producing cells from splenic and mesenteric
lymph node CD4+ T cells from Il6/ mice compared to their
WT counterparts (Figures S5D–S5F). In the context of in vitro
priming with WT splenic DCs, when splenic and mesenteric
lymph node CD4+ T cells from WT and Il6/ mice were
compared, they produced very similar amounts of IFN-g as
well as IL-17 (Figures S5G–S5I). Consistent with our earlier
observation, IL-6 neutralization did not affect IL-17 production
by all four groups of T cells (Figure S5G); however, IL-1 receptor
blockade with IL-1 receptor antagonist completely abolished
IL-17 secretion in the cultures (Figure S5H). The use of Il6/
splenic DCs in the in vitro culture system showed similar results
as IL-6 neutralization, further confirming that IL-6 is not required
for priming of Th17 cells when splenic DCs are used (Figure S5I).
Resident DCs in Priming Microenvironments Dictate
Cytokine Requirements for Th17 Cell Differentiation
To explore the possibility that DC populations resident in the
spleen and LP could primarily be responsible for the differentially
controlled lineage choices made by activated T cells in their
milieu, we examined the necessity of IL-6 for Th17 cell priming
induced by DCs from the spleen and LP. We purified DCs from
the spleens and LP of WT and Il6/mice and tested their ability
to prime naive WT CD4+ T cells into Th1 and Th17 cell lineages
in vitro. Splenic DCs from both WT and Il6/ mice induced
differentiation of T cells that secreted IFN-g as well as IL-17
(Figure 6A), thus validating that Th17 cell lineage development
induced by splenic DCs does not require IL-6. However, Il6/
LP DCs failed to induce differentiation of IL-17-secreting CD4+
T cells but induced differentiation of IFN-g-secreting CD4+Figure 2. Th17 Lineage Cells Are Present in the Peripheral Secondary
Deficient Mice
(A–E) CD4+ T cells from the spleens of slightly aged (16–20 weeks) WT and Il6/
populations.
(A) The sorted cells were cultured on plates coated with anti-CD3 and anti-CD28
(B and C) The sorted cells were stimulated with PMA and ionomycin and stained f
and combined data (C) of IFN-g- and IL-17-secreting CD4+TCRb+ cells from sev
(D) cDNAwasmade from freshly isolated naive andmemory CD4+ T cells and the t
RT-PCR.
(E) CD62LloCD44hi memory populations were stimulated as described in (B) a
by CD4+TCRb+IL-17+ and CD4+TCRb+IL-17 cells.
(F) Splenocytes from WT and Il6/ mice were stained for surface CD4, CD44, C
on CD4+CD44hiRORg+ cells. Shaded histograms, unstained control.
(G) Lamina propria lymphocytes (LPLs) were isolated from indicated mice after a
or RORg and T-bet directly.
(H) Enriched CD4+ T cells from LP of indicated strains of mice were cultured (30,0
for 48 hr and culture supernatants were assayed for IFN-g and IL-17.
Data are representative of three to five independent experiments. Bar graphs rep
ImmT cells (Figure 6B). WT LP DCs induced both IFN-g and IL-17
from activated CD4+ T cells (Figure 6B). These data demonstrate
that although both splenic DCs and LP DCs induce differentia-
tion of naive T cells into Th17 cells, splenic DCs do so indepen-
dent of IL-6, whereas LP DCs depend on IL-6 to induce Th17
lineage cells.
CD103+ DCs Determine the Dependency on IL-6
for Th17 Cell Differentiation
In order to understand the differences in the abilities of spleen
and LP DCs to induce Th17 cell priming, we began to investigate
the differences in DC populations that reside in these tissues.
Most strikingly, we noticed that CD103hi DCs are absent in the
spleen but comprise 20% of intestinal DCs (Figure 7A). These
CD103hi DCs (hereafter referred to as CD103+ DCs) were also
present at a low percentage in the skin-draining lymph nodes
but accumulated upon subcutaneous LPS injection (Figures
7A, 7B, and S6A). We sorted out CD103+ DCs from the intestine
and tested their ability to induce CD4+ T cell differentiation.
Both WT and Il6/ LP CD103+ DCs failed to induce detectable
IFN-g or IL-17 production from in-vitro-activated CD4+ T cells
(Figure 7C), consistent with a previous report showing that these
DCs preferentially induce Treg cells (Coombes et al., 2007). We
further explored the possibility that CD103+ DCs might impose
the requirement of IL-6 for Th17 cell priming. We depleted
CD103+ DCs from LP DCs and used the CD103 DC population
from Il6/ mice for in vitro priming assays. Consistent with our
prediction, the CD103 DC population from the LP resembled
the splenic DCs. WT and Il6/ CD103 LP DCs induced similar
quantities of IFN-g as well as IL-17, demonstrating that
CD103+ DCs in the gut are dominant over CD103 DCs and
prevent IL-6-independent priming of Th17 lineage cells (Fig-
ure 7C). Also, we found that lymph node-resident DCs from naive
mice, which have a very small CD103+ population, were able to
prime Th17 cells in vitro in the absence of IL-6 (Figure S6B).
However, when CD103+ DCs were recruited to the skin draining
lymph nodes, after subcutaneous immunization (Figure 7B),
IL-6 was required for Th17 cell priming (Figure 5B).
It has been previously reported that CD103+ DCs in the gut
make high quantities of TGF-b and retinoic acid (RA), both of
which have been shown to impact Th17 cell differentiation.Lymphoid Organs but Not Lamina Propria of the Intestines of IL-6-
mice were sorted to obtain CD62LhiCD44lo naive and CD62LloCD44hi memory
for 48 hr and culture supernatants were assayed for IFN-g and IL-17 by ELISA.
or intracellular IFN-g and IL-17 after permeabilization. Representative plots (B)
eral mice are shown.
ranscript amounts of Tbx21 (left) andRorc (right) weremeasured by quantitative
nd stained for IL-17 and RORg. Histograms show the expression of RORg
CR6, and intracellular RORg. Open histograms show the expression of CCR6
t least 2 weeks of cohousing and stained for IFN-g and IL-17 after stimulation,
00 CD4+ T cells/well) in the presence of plate-bound anti-CD3 and anti-CD28
resent mean ± SEM.
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A B Figure 4. Differential Requirement of IL-6 for Th17
Cell Lineage Commitment during Systemic and
Oral Infection
(A) Mice of indicated genotypes were infected orally with
1–2 3 109 CFU of Citrobacter rodentium. CD4+ T cells
were purified from the LP on day 8 postinfection and
stimulated with 3 mg/ml of Citrobacter rodentium soni-
cated lysates for 72 hr in the presence of naive WT B cells
as APCs. IL-17 concentrations in the culture supernatants
were then measured by ELISA. Citrobacter-specific IFN-g
was not detectable in any of the cultures.
(B) Mice of indicated genotypes were infected intraperi-
toneally with 103 CFU of Salmonella typhimurium.
CD4+ T cells from the spleen were isolated on day 7
postinfection and stimulated with 3 mg/ml of Salmonella
typhimurium sonicated lysates for 72 hr in the presence of naive B cells as APCs. IFN-g and IL-17 concentrations in the culture supernatants were thenmeasured
by ELISA. Cells cultured without Citrobacter- or Salmonella-sonicated lysates did not secrete any detectable IFN-g or IL-17.
Data are representative of three independent experiments. Bar graphs represent mean ± SEM.
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whereas high concentration of TGF-b inhibits it (Manel et al.,
2008). RA suppresses Th17 cell differentiation yet enhances
inducible regulatory T (iTreg) cell generation (Mucida et al.,
2007; Nolting et al., 2009). We first tested the possibility that
IL-6 could be required to overcome the suppressive effects of
TGF-b. If this were true, neutralization of TGF-b would lead to
IL-6-independent priming by LP DCs. However, neutralization
of TGF-b and inhibition of TGF-b signaling led to total abrogation
of Th17 cell priming (Figure S6C), even whenWT DCs were used
for priming. These experiments suggest that TGF-b is an
absolute requirement for Th17 cell priming. We also tested the
possibility that RA made by CD103+ DCs was responsible for
dictating the requirement of IL-6 for Th17 cell priming in the
gut. Addition of RA abrogated Th17 cell priming induced by
both WT and Il6/ DCs without significantly affecting Th1 cell
lineage development (Figure S6D). However, when a combina-
tion of TGF-b and RA was added to in vitro priming cultures,
there was total abrogation of Th17 cell priming induced by
Il6/ CD103 DCs but not by WT DCs (Figure 7D). Similarly,
TGF-b and RA also inhibited priming of Th17 cell lineage cells
by splenic DCs from Il6/ mice (Figure 7E). RA has been
demonstrated to enhance Smad3 phosphorylation and TGF-b
signaling (Mucida et al., 2007; Nolting et al., 2009). Consistent
with previous studies, IL-6 diminished the ability of TGF-b to
induce Smad3 phosphorylation in CD4+ T cells (Figure S6E).Figure 3. Differential Requirement of IL-6 for Th17 Cell Lineage Comm
Conditions
(A) Splenic naive (CD62LhiCD44lo) and memory (CD62LloCD44hi) CD4+ T cells
and ionomycin and stained for intracellular IFN-g and IL-17 (left two panels). Naiv
CD28 for 48 hr and culture supernatants were assayed for IFN-g and IL-17 (rig
detectable IFN-g or IL-17.
(B) LPLs were isolated from WT and Cd2-DNIl6st Tg mice and were either activ
IFN-g (left) or cultured in the presence of plate-coated anti-CD3 and anti-CD28
the culture supernatants (right).
(C–E) Cells from the spleen and lymph nodes of WT or Cd2-DNIl6st Tg mice wer
cells (MCs) were isolated from the spleen, liver, LP, and lung.
(C) MCs from the indicated organs were stimulated with PMA and ionomycin
intracellular IFN-g and IL-17 are shown.
(D and E) CD4+ T cells from indicated organs were stimulated with plate-bound
in the culture supernatants.
Data are representative of two or three independent experiments. Bar graphs re
ImmOur data therefore suggest that in the presence of CD103+
DCs that make both TGF-b and RA, IL-6 is required to overcome
their effects to allow Th17 cell priming in the gut. In the absence
of CD103+ DCs, as is the case in the spleen, Th17 cell priming
is independent of IL-6.
DISCUSSION
This study reveals several insights into how different priming
microenvironments determine the cytokine requirements for
Th17 cell lineage differentiation. Our previous work has shown
that Myd88/ mice fail to mount Th1 cell responses when
LPS is used as an adjuvant (Pasare and Medzhitov, 2004).
However, CD25+ Treg cell depletion restores Th1 cell priming
in Myd88/ mice (Pasare and Medzhitov, 2004). Because
several studies show reciprocal regulation of Treg and Th17
cell lineages (Bettelli et al., 2006; Korn et al., 2007), wewere inter-
ested in exploring whether depletion of Treg cells restores or
enhances Th17 cell priming in Myd88/ mice. Our investiga-
tions of T cell differentiation in Myd88/ mice revealed normal
Th1 cell priming but defective Th17 cell commitment in the
absence of Treg cells. This is an important result because it
suggests that, in the absence of MyD88 signaling, the lack of
Treg cells is permissive for Th1 cell priming but not Th17 cell
priming. Our results from transgenic mice that express MyD88
only in DCs and macrophages, but not in T cells, demonstrateitment in Different Priming Microenvironments under Lymphopenic
from WT and Cd2-DNIl6st Tg mice were sorted and stimulated with PMA
e and memory cells were also stimulated with plate-bound anti-CD3 and anti-
ht two panels). Data for memory cells are shown. Naive cells did not secrete
ated with PMA and ionomycin followed by staining for intracellular IL-17 and
for 48 hr after enrichment for CD4+ T cells and assayed for IL-17 secretion in
e transferred intravenously into Rag1/ recipients. After 7 days, mononuclear
and stained for intracellular IFN-g and IL-17. CD4+TCRb+ cells expressing
anti-CD3 and anti-CD28 for 48 hr and analyzed for IFN-g and IL-17 secretion
present mean ± SEM.
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AB
Figure 6. Dendritic Cells from the Spleen and Lamina Propria
Prime Th17 Cells in an IL-6-Independent and -Dependent Manner,
Respectively
(A) Purified naive WT CD4+ T cells were cultured in the presence of purified
splenic DCs from indicated strains and anti-CD3 (10 ng/ml) for 5 days in the
presence or absence of the TLR2 ligand Pam3CSK4 (100 ng/ml). Five days
later, culture supernatants were collected and analyzed for IFN-g (left) and
IL-17 (right) by ELISA.
(B) Purified naive WT CD4+ T cells were cultured in the presence of purified
lamina propria DCs from indicated strains and anti-CD3 (10 ng/ml) for 5 days in
the presence or absence of the TLR2 ligand Pam3CSK4 (100 ng/ml). Five days
later, culture supernatants were collected and analyzed for IFN-g (left) and
IL-17 (right) by ELISA.
Data are representative of three independent experiments. Bar graphs
represent mean ± SEM.
A
B
Figure 5. The Cutaneous Immune System Primes Th17 Cells in an
IL-6-Dependent Manner
(A) CD4+ T cells from the inguinal, popliteal, brachial, and axillary lymph
nodes of WT and Il6/ mice were stimulated with plate-bound anti-CD3 and
anti-CD28 for 48 hr and cytokine production was assayed in the culture
supernatants.
(B) 2.5 3 106 purified CD45.1 congenic OT-II T cells were transferred intra-
venously into WT or Il6/ mice (CD45.2 background). The recipients were
then immunized in the footpads with 50 mg/fp of OVA and 5 mg/fp of LPS
emulsified in IFA. CD4+ T cells were enriched by negative selection from the
draining lymph nodes on day 5 postimmunization, and CD4+CD45.1+ OT-II
T cells were recovered by cell sorting followed by stimulation with plate-bound
anti-CD3 and anti-CD28 for 48 hr. Cytokine secretion was analyzed by ELISA
in the culture supernatants.
Data are representative of two independent experiments. Bar graphs repre-
sent mean ± SEM.
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Tissue-Specific Requirements for Th17 Cell Primingthat MyD88 in T cells is absolutely required for Th17 cell
commitment. Requirement for MyD88 signaling in CD4+ T cells
is explained by the critical role for IL-1 in priming of Th17 lineage
cells. Several studies have demonstrated that IL-6 is a master
inducer of Th17 cell differentiation (Acosta-Rodriguez et al.,
2007; Bettelli et al., 2006; Ivanov et al., 2006; Veldhoen et al.,
2006; Zhou et al., 2007). It has also been argued that IL-6
regulates the induction of Th17 lineage cells by enhancing the
expression of IL-1R on CD4+ T cells (Chung et al., 2009).
Because we observed normal Th17 cell priming in vitro when
using Il6/ DCs for priming of naive T cells, we decided to
further investigate the exact roles of IL-1 and IL-6 in Th17 cell
lineagecommitment in vivo.Asmiceage, theydevelopasubstan-
tial proportion of CD44hiCD62Llo cells in the spleen, representing
antigen-experienced T cells. As revealed in our results,1018 Immunity 35, 1010–1022, December 23, 2011 ª2011 Elsevier InCD44hiCD62LloCD4+ T cells from WT, Myd88/, and Il6/
mice secreted IFN-g. However, CD44hiCD62LloCD4+ T cells
from Myd88/ and Il1r1/ mice failed to secrete appreciable
quantities of IL-17. Surprisingly, CD44hiCD62Llo cells from Il6/
mice made similar quantities of IL-17 as did WT T cells. WT and
Il6/ mice also had similar proportions of IL-17-secreting cells,
as measured by intracellular staining. More importantly, the
memory cell pool from Il6/ mice expressed RORgt. These
results suggest that induction of the transcription factor RORgt,
and subsequent Th17 cell lineage commitment, is not dependent
on IL-6 in CD4+ T cells of the spleen.
Several reports suggest that IL-1 and IL-6, along with TGF-b,
play a major role in the induction of Th17 cells. It has also been
shown previously that LPLs from Il6/ mice make reduced
IL-17 as assayed by intracellular staining as well as quantitative
polymerase chain reaction (PCR) (Ivanov et al., 2006). In agree-
ment with this, we found that CD4+ T cells from the LP of Il6/
mice did not make detectable IL-17. We also found that CD4+
T cells from the LP of Myd88/ and Il1r1/ mice secreted
substantially lower or nondetectable quantities of IL-17 when
compared to WT mice. These results along with our infection
experiments argue that both IL-1 and IL-6 are required for
generation of Th17 cells in the LP of the gut whereas IL-1 is
critical for Th17 cell lineage development in the spleen. It is also
remarkable that when naive T cells are transferred into Rag1/
mice, cells that are defective for gp130 signaling secrete IL-17c.
A B
C
D
E
Figure 7. CD103+ DCs Dictate the Requirement of IL-6 for Th17 Cell Priming
(A) Proportion of CD103+ DCs in the spleen, the inguinal lymph nodes, and the LP. Cells from the CD11c+ MHC class II+ gate are shown.
(B) WT mice were injected with 10 mg of LPS in the left footpad and PBS in the right footpad. The inguinal lymph nodes were collected 21 hr later and stained for
CD11c, MHC class II, and CD103. Cells from the CD11c+ MHC class II+ gate are shown.
(C) Purified naiveWTCD4+ T cells were cultured in the presence of purified CD103+ and CD103 LP DCs from indicated strains and anti-CD3 (10 ng/ml) for 5 days
in the presence or absence of the TLR2 ligand Pam3CSK4 (100 ng/ml). Five days later, culture supernatants were collected and analyzed for IFN-g (left) and IL-17
(right) by ELISA.
(D and E) Purified naive WT CD4+ T cells were cultured with (D) LP CD103DCs or (E) splenic DCs from indicated strains and anti-CD3 (10 ng/ml) for 5 days in the
presence or absence of the TLR2 ligand Pam3CSK4 (100 ng/ml). TGF-b (0.3 ng/ml) and RA (0.1 nM) was added into the culture as indicated. Five days later,
culture supernatants were collected and analyzed for IFN-g (left) and IL-17 (right) by ELISA. Data are representative of three independent experiments. Bar graphs
represent mean ± SEM.
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Tissue-Specific Requirements for Th17 Cell Primingwhen isolated fromthespleenand liverbut fail to doso in the lungs
and the LP of the intestines. This unique differentiation pattern
suggests that sterile and commensal bacteria-rich microenviron-
ments impose different rules for Th17 cell lineage commitment.ImmIt is also important to note here that skin draining lymph
nodes have Th17 lineage cells, but subcutaneous immunization
fails to induce Th17 cell priming in Il6/ mice. The presence of
Th17 lineage cells in the lymph nodes can be explained by theunity 35, 1010–1022, December 23, 2011 ª2011 Elsevier Inc. 1019
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Tissue-Specific Requirements for Th17 Cell Primingpossibility that after splenic priming, Th17 cells migrate from
the spleen to these lymph nodes. However, upon subcuta-
neous immunization, IL-6 was required for local priming of
Th17 lineage cells in the lymph nodes. It has been recently
proposed that IL-6 induces Th17 cell lineage commitment
through upregulation of IL-1R. Because Il6/ mice have defec-
tive Th17 cell lineage priming only in the lamina propria and skin
draining lymph nodes, IL-6 could be controlling Th17 cell
lineage commitment through regulation of the IL-1R only in
the LP of the gut and skin draining lymph nodes but not in
the spleen.
There are well-known differences in the populations of the
DCs residing in the gut and peripheral secondary lymphoid
organs (Coombes and Powrie, 2008); however, our results
provide further insights into the priming abilities of LP DCs.
Whereas splenic DCs induce normal Th17 cell priming, LP DCs
fail to do so in the absence of IL-6. CD103+ DCs are of interest
because of some unique abilities that have been ascribed to
them. CD103+ DCs in the intestine have been shown to imprint
T cells with gut-homing molecules such as the chemokine
receptor CCR9 (Annacker et al., 2005; Jaensson et al., 2008).
They are also responsible for inducing regulatory T cells in the
intestine through the production of TGF-b and retinoic acid
(Coombes et al., 2007), thereby contributing to the control of
colitis (Varol et al., 2009). Our findings have ascribed an addi-
tional function to CD103+ DCs, of regulating the requirement
for Th17 cell priming in the gut and the skin draining lymph
nodes. We have demonstrated that CD103 cells are respon-
sible for IL-6-independent priming of Th17 lineage cells. This
conclusion is strongly supported by the fact that splenic
DCs are all CD103 and also by the fact that CD103 DC
populations from the lamina propria could induce Th17 cell
priming in the absence of IL-6. There was normal presence of
Th17 lineage cells in the lymph nodes of Il6/ mice and
lymph-node-resident DCs could prime Th17 lineage cells
in vitro, but subcutaneous challenge with TLR ligands led to
accumulation of CD103+ DCs in the draining lymph nodes
and these DCs seemed to determine the requirement of IL-6
for Th17 cell priming. Interestingly, CD103+ DCs did not seem
to play a role in regulating Th1 cell priming. CD103+ DCs are
known to induce generation of Foxp3+ iTreg cells (Coombes
et al., 2007), and our study supports the notion that these
DCs impose a requirement of IL-6 for Th17 cell priming by
CD103 DCs. Our data also demonstrate that TGF-b is abso-
lutely essential for driving Th17 cell differentiation by DCs.
However, a combination of TGF-b and RA, which provides
a more physiological microenvironment because they are both
made by CD103+ DCs, had an inhibitory effect on Th17 cell
priming in the absence of IL-6, both by splenic and LP DCs.
These data are consistent with earlier studies showing that RA
enhances phosphorylation of Smad3 in response to TGF-b
treatment (Nolting et al., 2009) and that activation of STAT3
by IL-6 leads to desensitization of TGF-b signaling (Jenkins
et al., 2005). Our data therefore suggest that when CD103+
DCs are part of the DC population involved in T cell priming,
TGF-b and RA made by these DCs have a dominant role in
determining the outcome of T cell differentiation. Consequently,
in the absence of IL-6, CD103+ DCs play a dominant role leading
to generation of Foxp3+ iTreg cells. An earlier study demon-1020 Immunity 35, 1010–1022, December 23, 2011 ª2011 Elsevier Instrated that in mice with DCs incapable of making active
TGF-b, the proportion of Foxp3-positive CD4+ T cells is reduced
in the LP but not in the spleen (Travis et al., 2007). Conversely,
our results demonstrate that the absence of IL-6 enhanced the
proportion of Foxp3-positive CD4+ T cells only in the LP but
not in the spleen.
In the systemic immune system, which is generally sterile,
IL-1-mediated signaling seems to be sufficient to support Th17
cell lineage differentiation. In contrast, the mucosal and cuta-
neous surfaces are constantly exposed to commensal microor-
ganisms and appear to have stringent requirements to induce
Th17 cell priming. Because Th17 cells are pathogenic and can
cause autoimmunity, it is particularly important for the mucosal
and cutaneous immune systems to maintain a balance between
immunity and tolerance. Because IL-6 is highly proinflammatory,
the mucosal and cutaneous systems may interpret the presence
of IL-6 as a critical signal implicating pathogen invasion and
differentiate active infection from steady-state sampling of the
commensal microflora and self antigens from the tissues. IL-6
seems to act as an additional checkpoint for inducing Th17 cells
in the gut as well as in the skin draining lymph nodes, guiding the
lineage choice between inhibitory iTreg cells and inflammatory
Th17 cells. It has been reported that CD103+ DCs change their
suppressive behavior in colitic mice (Laffont et al., 2010) and it
is possible that there could be transient Th17 cell priming in
the guts of IL-6-deficient mice when CD103+ DCs are function-
ally shut down and it would be worthwhile to explore the role
of IL-6 in survival andmaintenance of Th17 cells generated under
such conditions.
In summary, our study provides important insights into how
priming microenvironments guide the cytokine requirements
for the development of Th17 lineage cells. In commensal-bearing
sites such as the intestine and the skin, IL-1 is critical, but IL-6
acts as a second checkpoint for Th17 cell lineage commitment.
More importantly, our study discovers that DC populations in the
spleen, lymph nodes, and LP of the intestines are responsible
for determining the cytokine requirements for Th17 cell priming
in respective tissues. These findings could have important
implications for designing therapies for systemic and mucosal
autoimmunity, as well as for choosing routes of vaccination for
inducing protective Th17 cell responses.
EXPERIMENTAL PROCEDURES
Mice
Myd88/Trif/, Tlr2/Tlr4/, Myd88/, Cd11c-Myd88 Tg, Cd2DNIl6st
Tg, Il6/, Il1r1/, and Rag1/mice were bred and maintained at the animal
facility of UT Southwestern Medical Center. Control C57BL/6 mice were
obtained from UT Southwestern mouse breeding core facility. All mouse
experiments were done as per protocols approved by Institutional Animal
Care and Use Committee (IACUC) at UT Southwestern Medical Center.
Generation of Cd2-DNIl6Tg Mice
A dominant-negative Il6st described previously (Kumanogoh et al., 1997) was
cloned into VA-CD2 plasmid, linearized, and injected into C57BL/6 blastocysts
by UT Southwestern Transgenic and Knockout Core Facility.
T Cell Purification
Spleens were harvested from 8- to 12-week-old or 16- to 20-week-old
mice. CD4+ T cells were purified from the spleens by negative selection as
previously described (Pasare and Medzhitov, 2004). CD4+CD62LhiCD44loc.
Immunity
Tissue-Specific Requirements for Th17 Cell Primingand CD4+CD62LloCD44hi T cells were purified with biotin anti-CD62L
followed by anti-biotin microbeads and sorted with the AutoMACS sorter
(Miltenyi Biotec, Auburn, CA).
Isolation of Lamina Propria Lymphocytes
Lamina propria lymphocytes (LPL) were isolated as described previously
(Ivanov et al., 2008). CD4+ T cells were enriched by negative selection and
purity of CD4+ T cells was confirmed by staining with anti-CD4.
Staining and Flow Cytometry
Cells were stained with relevant antibodies for 30min on ice and were washed.
For intracellular staining of cytokines, cells were stimulated with 50 ng/ml
phorbol myristate acetate (PMA) and 1 mM ionomycin in the presence of
1 mg/ml brefeldin A for 5 hr, followed by surface staining, fixed with 4%
paraformaldehyde, permeabilized with 0.3% saponin, and stained for intra-
cellular cytokines. For transcription factor staining, the Foxp3 Staining
Buffer Set from Biolegend was used for fixation and permeabilization of
freshly isolated cells. The stained cells were analyzed with a FACSCalibur
flow cytometer (BD Biosciences). Data were analyzed with FlowJo software
(Tree Star).
Quantitative Real-Time Polymerase Chain Reaction
Freshly sorted cells were lysed immediately in TRIzol Reagent (Invitrogen) and
RNA was extracted according to manufacturer’s instructions. cDNA was
synthesized with M-MLV Reverse Transcriptase (Invitrogen). Tbx21 and Rorc
(specific for the RORgt isoform) transcripts were measured with DyNAmo
SYBR Green qPCR Kit (Finnzymes). Primer sequences are listed in Supple-
mental Information.
Ex Vivo T Cell Stimulation
Tissue culture plates were coated with 0.5 mg/ml of anti-CD3 and 0.5 mg/ml of
anti-CD28 at 37C for 2 to 3 hr and washed three times before use. Sorted
CD4+ T cells were plated at 5 3 105 cells/well in 48-well plates and LP CD4+
T cells were plated at 3 3 104 cells/well. Cells were stimulated for 48 hr
and culture supernatants were assayed for cytokine production.
Cell Transfer
5 3 107 mononuclear cells isolated from the spleen and lymph nodes from
young naive donors (6 weeks of age) were transferred into Rag1/ recipients
through the tail vein. Differentiation of the donor cells in multiple organs was
analyzed on day 7 posttransfer.
Infections
Mice were infected with 1–2 3 109 colony-forming units (CFU) of Citrobacter
rodentium (strain ICC168) suspended in 100 ml PBS by oral gavage or 1000
CFU of Salmonella typhimurium (strain SL1344) suspended in 500 ml PBS by
intraperitoneal injection.
Dendritic Cell Preparation
Mononuclear cells from the spleen, lymph nodes (inguinal, popliteal, brachial,
and axillary), or the LP were labeled with anti-CD11c andMHC-II antibody and
CD11c+MHC-II+ cells were sorted on a MoFlo cell sorter (BD Biosciences).
In Vitro T Cell Priming
Purified naive CD62LhiCD44loCD4+ T cells (3 3 105/well) were cultured
with splenic DCs (6 3 104/well) and anti-CD3 (10 ng/ml) in the presence or
absence of TLR ligands. Alternatively, purified naive CD62LhiCD44loCD4+
T cells (1.5 3 105/well) were cultured with sorted LP DCs (3 3 104/well) and
anti-CD3 (10 ng/ml) in the presence or absence of TLR ligands. Supernatants
were analyzed for cytokines after 5 days of culture.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at doi:10.1016/j.
immuni.2011.10.013.ImmACKNOWLEDGMENTS
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